It is well known that type 2 diabetes an endocrine disease. Among glucose-lowering medications, α glucosidase which a membrane bound enzyme at the epithelium of small intestine catalyses cleavage glucose from disaccharide are effective for delaying absorption. i.e., inhibitors delay absorption ingested carbohydrates, reducing postprandial glucose. Pancreatic α-amylase key in digestive system an...